Metoprolol (Lopressor): Uses, Forms, Warnings

What is metoprolol?

Metoprolol is a medicine used for the treatment of several cardiovascular conditions. The original content lists its use in arrhythmias, angina pectoris, high blood pressure, prevention after myocardial infarction, migraine prophylaxis, and hyperthyroidism.

The active ingredient may appear in different salt forms, including metoprolol fumarate, metoprolol succinate, and metoprolol tartrate.

Brand names mentioned in the original content include Lopressor, Toprol-XL, Metoprolol Tartrate, and Metoprolol Succinate ER.

How metoprolol works

Metoprolol is described as a cardioselective beta-blocker that acts on β1 receptors in the heart. The original content also notes that it has no membrane stabilizing effect and no intrinsic sympathomimetic activity.

In practical terms, this means it is used to help manage certain heart-related symptoms and conditions under medical supervision.

Therapeutic uses listed in the original content

The original content groups metoprolol use by route and formulation:

• Oral use: high blood pressure, angina pectoris, cardiac arrhythmias such as supraventricular tachycardia, maintenance treatment after myocardial infarction, and migraine prophylaxis.
• Delayed-release form: functional cardiac disorders with palpitations.
• Non-retardant form: hyperthyroidism.
• Intravenous use: arrhythmias such as supraventricular tachycardia, and confirmed or suspected myocardial infarction.

Dosage information from the source

The original content includes example dosing ranges and schedules. Because dosing depends on the exact product, formulation, age, medical history, and clinical situation, the most reliable reference is the official leaflet or prescribing information for the specific metoprolol product.

If you are checking a prescription, confirm the following with a pharmacist or prescriber:

• whether the product is tartrate or succinate,
• whether it is immediate-release or extended-release,
• the intended route: oral or intravenous,
• the exact schedule written on the prescription label.

Contraindications listed in the source

The original content lists the following situations where metoprolol should not be used:

• Hypersensitivity to metoprolol or other beta-blockers
• Second- or third-degree atrioventricular block
• Decompensated cardiac insufficiency, including pulmonary edema, hypoperfusion, or hypotension
• Continuous or intermittent inotropic treatment that acts by antagonism with β receptors
• Sinus bradycardia
• Sick sinus syndrome unless a permanent pacemaker is implanted
• Cardiogenic shock
• Severe peripheral arterial circulatory disorder
• Myocardial infarction with heart rate below 45 bpm, P-Q interval above 0.24 sec, or systolic pressure below 100 mm Hg

Warnings and precautions

The source highlights several precautions that may require closer monitoring or dose adjustment by a clinician:

• Severe liver failure
• Asthma
• Heart failure
• Pheochromocytoma, when used with an alpha blocker
• Upcoming surgery, where the anesthetist should be informed
• Possible worsening of peripheral arterial circulatory disorders
• Possible aggravation of pre-existing atrioventricular conduction disorders of moderate degree
• Bradycardia that worsens during treatment
• Risk of coronary events during beta-blocker withdrawal
• Need for cardiac monitoring in some situations

Liver impairment

The original content advises caution in severe liver impairment and notes that dose reduction should be considered.

Drug interactions mentioned in the original content

Metoprolol may interact with other medicines. The original content specifically mentions:

• Clonidine: if treatment must be stopped, the beta-blocker should be discontinued first, several days before clonidine.
• Quinidine and amiodarone: may increase negative inotropic and negative dromotropic effects.
• Inhaled anesthetics: may increase cardiodepressive effect.
• Rifampicin: may decrease plasma concentration.
• Cimetidine: may increase plasma concentration.
• Indomethacin: may reduce effect.
• Hypoglycemic medicines: metoprolol may modify glucose concentration in people with diabetes.
• Lidocaine: toxicity may increase.
• Verapamil-type calcium antagonists: should not be given intravenously with beta-blockers.

Pregnancy and breastfeeding

The original content states that metoprolol may cause side effects in the fetus, but may be used if necessary.

For breastfeeding, the source says it should not be used during lactation unless its use is considered essential. It also notes that beta-blockers may cause effects such as bradycardia in the infant, although the amount passed through breast milk is described as negligible in relation to a possible beta-blocking effect at usual therapeutic doses.

If pregnancy or breastfeeding applies, the official leaflet and a healthcare professional should be consulted for product-specific advice.

Effects on driving and using machines

The source advises patients to test their reaction before driving or using machines because dizziness or tiredness may occur.

Possible adverse reactions listed

The original content lists the following side effects:

• Bradycardia
• Postural hypotension
• Cold hands and feet
• Palpitations
• Tiredness
• Headaches
• Nausea
• Abdominal pain
• Diarrhea
• Constipation
• Effort dyspnea

What to verify in the official leaflet

Because metoprolol products can differ by formulation and brand, it is useful to confirm the following in the official medication guide or package leaflet:

• the exact active ingredient and salt form,
• whether the tablet is immediate-release or extended-release,
• how the product should be taken,
• which symptoms require urgent medical attention,
• which medicines should be reviewed for interactions.

Safety reminder

Do not use this information to self-treat chest pain, palpitations, fainting, severe shortness of breath, or suspected heart attack. Seek urgent medical care for severe or sudden symptoms, and always follow the instructions on the prescription label and official leaflet.

Frequently asked questions

Source references in the original content included FDA medication guide resources and ingredient databases such as UNII, ChemIDplus, DrugPortal, PubChem, and NCI Thesaurus.